Federated Hermes’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,000
Closed -$1.86M 2172
2017
Q3
$1.86M Sell
10,000
-4,000
-29% -$709K 0.01% 955
2017
Q2
$2.41M Hold
14,000
0.01% 830
2017
Q1
$2.3M Sell
14,000
-6,000
-30% -$997K 0.01% 854
2016
Q4
$2.87M Buy
+20,000
New +$3.01M 0.01% 736

Other funds holding AMGN

Federated Hermes's AMGN Position: Q1 2026 in Review

Federated Hermes reduced its Amgen (AMGN) stake by 37% in Q1 2026, selling an estimated $236M and leaving 1,136,518 shares worth $400M. The position accounts for 0.65% of the portfolio, ranked #37.

Federated Hermes first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $672M in Q3 2023. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Federated Hermes held 1,136,518 shares of Amgen worth $400M as of Q1 2026.
  • Federated Hermes sold 662,922 Amgen shares in Q1 2026, an estimated $236M.
  • Amgen made up 0.65% of Federated Hermes's portfolio in Q1 2026, its #37 holding.
  • Federated Hermes first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Federated Hermes's Amgen position peaked at $672M in Q3 2023.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.